JANUMET Certification

[Anonymous]

I thought this was a little over the top in terms of content. Will we ever learn.

 

[Anonymous]

Which Reps are selling this product?

 

[Anonymous]

Which Reps are selling this product?

Upon release, it is an all hands on deck during the first 6 to 12 months. We want to continue to establish ourselves as a major player and force in the DM market. Despite what appears on CP, Januvia sales continue to be splendid! It was nice to see the article that called Merck a major player and "leading" pharmaceutical firm. I think we've almost returned to our status during the glory years.

 

[Anonymous]

Upon release, it is an all hands on deck during the first 6 to 12 months. We want to continue to establish ourselves as a major player and force in the DM market. Despite what appears on CP, Januvia sales continue to be splendid! It was nice to see the article that called Merck a major player and "leading" pharmaceutical firm. I think we've almost returned to our status during the glory years.

Leading firm? Are you serious? You have one product on the market. You are not considered a leader by any means. Perhaps if Januvia overtakes the top spot in the market that honor will be justified. But until then I don't see how that could be. What happens if post marketing data shows something the clinical trials didn't pick up? It happens often once a product is opened to the public as a whole. Don't get too cocky yet. It has only been a few months and time will tell what the real uptake will be.

 

[Anonymous]

We are doing all day certifications with the RBD present. That will be a fun day in a few weeks.

 

[Anonymous]

We are doing all day certifications with the RBD present. That will be a fun day in a few weeks.

Our SBD is allowing our BM to take care of certifying us. It should be easy.

 

[Anonymous]

I personally don't give a shit, as long as we continue to slam Novartis and stay ahead of their "miracle" Galvus.

 

[Anonymous]

Watch out for Exubera...
Pfizer's best sales force is now selling it.

 

[Anonymous]

Watch out for Exubera...
Pfizer's best sales force is now selling it.

Are you joking? Pfizer with irrational exubera? Aventis made out when Pfizer paid the 1.5 billion for 100% of the rights to irratioanl Exubera. Exubera is a pipe dream it will never be accepted by the medical community. Add to this the fact Pfizer is dissentegrating and you have a pretty bad situation.

 

[Anonymous]

I thought this was a little over the top in terms of content. Will we ever learn.

Over the top, like what? You can't handle it, too much, too much for your pea brain, sheeeeze - get a life and try to actually sell something.

 

[Anonymous]

I personally don't give a shit, as long as we continue to slam Novartis and stay ahead of their "miracle" Galvus.

And this seems quite likely, given the lack of FDA approval. While ex-US revenue has grown, it is not a realistic threat, especially when looking at relative revenue growth over the last two years. There is a more in-depth analysis here: http://pharmapricing.org

 

[Anonymous]

Resurrecting a 4 year old post....what are we trying to sell here?? Nice try!